EYE nova eye medical limited

Ann: Trading Update for Year Ended 30th June 2018, page-5

  1. nk
    3,203 Posts.
    lightbulb Created with Sketch. 169
    If you scroll down to page 25 or thereabouts you can see Glaukos March 18 figures for sales/costs

    http://d18rn0p25nwr6d.cloudfront.net/CIK-0001192448/8252b98f-b4c9-41a3-802e-96731834437b.pdf

    Note that sales growth was not the impressive quarter on quarter either

    Also note the substantial selling, general and admin costs.  They have to throw a lot of  money at marketing to ramp up sales. These cost rose significantly yoy

    Also note the massive gross profit margin. This is why the market has put such a big price on Glaukos, it is thinking, if they get sales traction they will generate huge cash flow. Question is how much it cost to get the sales

    From memory the gross margin on itrack was pretty solid as well.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
12.5¢
Change
0.000(0.00%)
Mkt cap ! $35.51M
Open High Low Value Volume
12.5¢ 13.0¢ 12.5¢ $12.63K 100.9K

Buyers (Bids)

No. Vol. Price($)
4 158751 12.5¢
 

Sellers (Offers)

Price($) Vol. No.
13.0¢ 571121 3
View Market Depth
Last trade - 11.46am 16/07/2025 (20 minute delay) ?
EYE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.